The Drug Enforcement Administration has reversed its decision to the scheduling proposal that would have placed five tryptamine hallucinogens, as identified in this proposed rule, in schedule I of the Controlled Substances Act.

PharmaTher is a specialty life science company focused on the research and development of psychedelics. They have recently filed patents with the FDA to mix FDA approved neurological drugs with Ketamine, Psilocybin, Cannabis, and MDMA to treat neurological disorders using GelMA micro-needle technology and transdermal patches.

Pharmadrug is a specialty pharmaceutical company involved in the research, development, and commercialization of controlled substances and all-natural medicines including psychedelics like DMT, cannabis, and naturally occurring drug derivatives.

Today we thank the United States Veterans for their service but, do we as a nation, make sure they are getting the proper treatment required to combat PTSD on American Soil?

FDA is helping to speed up the process of researching and approving psilocybin, MDMA, and Ketamine for breakthrough treatments in patients with Depression, Anxiety, PTSD, and even addiction.

Patients already have a Right to Try through the FDA’s humanitarian expanded access program, which gives them hope while protecting them from greedy exploitation. Does the federal Right to Try Act Help or Hurt terminally ill patients and take away important safety protections already in place?